FindTrial
Sign In

Screening of differentially expressed genes in primary osteoporosis based on transcriptome sequencing technology

Screening of differentially expressed genes in primary osteoporosis based on transcriptome sequencing technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065383
Enrollment
Unknown
Registered
2022-11-03
Start date
2022-11-07
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis

Interventions

osteoporosis group:no
Non osteoporosis group:no

Sponsors

Qingdao Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. The patients were divided into osteoporosis group and non osteoporosis group by dual energy X-ray absorptiometry; 2. Pedestrian hip replacement patients.

Exclusion criteria

Exclusion criteria: 1. Patients with infection signs confirmed by preoperative or intraoperative examination specimens; 2. The patient was complicated with severe cardiovascular and cerebrovascular diseases, rheumatic immunity, endocrine metabolic abnormalities and other diseases; 3. Those who have received anti osteoporosis drugs or hormone treatment within 1 year.

Design outcomes

Primary

MeasureTime frame
differentially expressed genes;—

Countries

China

Contacts

Public ContactQi Shubin

Qingdao Hospital of Traditional Chinese Medicine

mr.qishubin@163.com+86 13863995106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026